Myomo (MYO) Capital Expenditures (2017 - 2025)
Myomo's (MYO) quarterly Capital Expenditures came in at $1.9 million in Q3 2025, up 506.49% on a YoY basis from $320704.0 in Q3 2024, and up 432.63% quarter-over-quarter from $365174.0 in Q2 2025.
Analysis
Myomo (MYO) Capital Expenditures (2017 - 2025) Analysis & Trends
Myomo (MYO) has reported Capital Expenditures for 9 consecutive years, with $1.9 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures rose 506.49% year-over-year to $1.9 million; the trailing twelve-month figure through Sep 2025 stood at $3.8 million (up 622.64% YoY), and the FY2024 full-year result was $1.4 million, up 832.77% from the prior year.
- Capital Expenditures improved to $1.9 million in Q3 2025 per MYO's latest filing, from $365174.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.9 million in Q3 2025 and bottomed at $3385.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $259215.2 across 5 years, with a median of $54093.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures plunged 89.55% in 2022, then jumped 2616.72% in 2024.
- Over 5 years, Capital Expenditures stood at $23935.0 in 2021, then plunged by 85.86% to $3385.0 in 2022, then jumped by 835.45% to $31665.0 in 2023, then surged by 2616.72% to $860248.0 in 2024, then surged by 126.1% to $1.9 million in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.9 million, $365174.0, and $670688.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 365,174.00 |
| Mar 31, 2025 | 670,688.00 |
| Dec 31, 2024 | 860,248.00 |
| Sep 30, 2024 | 320,704.00 |
| Jun 30, 2024 | 119,365.00 |
| Mar 31, 2024 | 59,808.00 |
| Dec 31, 2023 | 31,665.00 |
| Sep 30, 2023 | 54,093.00 |
| Jun 30, 2023 | 14,973.00 |
| Mar 31, 2023 | 45,085.00 |
| Dec 31, 2022 | 3,385.00 |
| Sep 30, 2022 | 5,736.00 |
| Jun 30, 2022 | 52,793.00 |
| Mar 31, 2022 | 49,879.00 |
| Dec 31, 2021 | 23,935.00 |
| Sep 30, 2021 | 54,883.00 |
| Jun 30, 2021 | 203,155.00 |
| Mar 31, 2021 | 44,489.00 |
| Dec 31, 2020 | 15,458.00 |